Press Release: Sanofi Accelerates Global Shipping of Beyfortus to Prepare Healthcare Providers Months Ahead of 2025-2026 RSV Season

Sanofi starts shipping RSV drug early as rival nears market

As an FDA decision nears from a rival MSD drug, Sanofi is speeding up the rollout of RSV antibody Beyfortus to get ahead of this year's season

Sanofi Speeds Up Global Beyfortus Shipments Ahead Of 2025-2026 RSV Season

(RTTNews) - Sanofi S.A. (SNYNF, SNY) is speeding up the global distribution of Beyfortus (nirsevimab) to ensure healthcare providers have access well in advance of the 2025-2026 RSV season. Shipments will begin in early third quarter, months ahead of the typical RSV season, which

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season

Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Paris, June 9, 2025. Sanofi is...

Vaccine rollout halves infant RSV hospitalisations

Early data shows the government's $174.5m ”world-leading” free respiratory syncytial virus (RSV) immunisation program for babies and expecting mothers has been a major success. The Immunisation Foundation of Australia (IFA) has reported a 50 per cent drop in the babies admitted to hospital with RSV as compared with this time last year. This is the first hospitalisation data to be analysed since the introduction of the National RSV Mother and Inf…

Sanofi ramps up distribution of Beyfortus ahead of RSV season

Respiratory syncytial virus (RSV) already represents a blockbuster business with Sanofi reporting that Beyfortus (nirsevimab) hit global sales of €1.7 billion (roughly $1.77 billion) in its first full year on the market in 2024. Beyfortus protects infants from lung infections caused by RSV Beyfortus can help prevent a serious lung disease associated with RSV in… The post Sanofi ramps up distribution of Beyfortus ahead of RSV season appeared firs…

Sanofi to Begin Globally Shipping Beyfortus Ahead of RSV Season

In an effort to greater prepare HCPs and to avoid potential shortages, the company targets Q3 as the shipment date.